Cited by 144Dementia and Cognitive Impairment ResearchCerebrospinal fluid and hydrocephalusCancer-related cognitive impairment studies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Trajectories of brain loss in aging and the development of cognitive impairment

Carlson, N. E., Moore, M. M., Dame, A., Howieson, D., Silbert, L. C., Quinn, J. F., Kaye, J. A.·2008·Neurology

DOI 10.1212/01.wnl.0000280577.43413.d9

Open this paper in CoChat — free account

Abstract

Background The use of volumetric MRI as a biomarker for assessing transitions to dementia presumes that more rapid brain loss marks the clinical transition from benign aging to mild cognitive impairment (MCI). The trajectory of this volume loss relative to the timing of the clinical transition to dementia has not been established. Methods The authors annually evaluated 79 healthy elderly subjects for up to 15 consecutive years with standardized clinical examinations and volumetric brain MRI assessments of ventricular volume. During the study period, 37 subjects developed MCI. A mixed effects model with a change point modeled the pattern of brain volume loss in healthy aging compared with subjects diagnosed with MCI. Results The brain loss trajectory of subjects developing MCI during follow-up differed from healthy aging in a two-phase process. First, the annual rate of expansion of ventricular volume decreased with age; however, the annual rates of expansion were greater in those who developed cognitive impairment during follow-up compared with those who did not. Further, subjects who developed MCI had an acceleration of ventricular volume expansion approximately 2.3 years prior to clinical diagnosis of MCI. Conclusions Ventricular expansion is faster in those developing mild cognitive impairment years prior to clinical symptoms, and eventually a more rapid expansion occurs approximately 24 months prior to the emergence of clinical symptoms. These differential rates of precli…

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000280577.43413.d9

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Statistical Inference
Casella, G., & Berger, R. L. (1993) · Chapman & Hall/CRC eBooks · doi:10.1201/9781003456285 · Cited by 5,835
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Two Factor Index of Social Position
Hollingshead, A. B. (1957) · Cited by 3,757
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men
Vasan, R. S., Beiser, A., Seshadri, S. S., Larson, M. G., Kannel, W. B., D’Agostino, R. B., & Levy, D. A. (2002) · JAMA · doi:10.1001/jama.287.8.1003 · Cited by 1,403
The Development, Validity, and Reliability of the Oars Multidimensional Functional Assessment Questionnaire
Fillenbaum, G. G., & Smyer, M. A. (1981) · Journal of Gerontology · doi:10.1093/geronj/36.4.428 · Cited by 1,127

Show all 31 references

Research works printed but not linked: 2

10.1212/WNL.43.10.1882 · DOI
Clayton D Hills M. Statistical model in epidemiology. Oxford UK: Oxford University Press 1993.

Sorted by citations

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial
Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813
“An intermediate rate of atrophy is found in people with mild cognitive impairment (MCI) [6,7,8,9,10,11].”
Resistance Training and Executive Functions: A 12-Month Randomized Controlled Trial
Liu-Ambrose, T. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.494 · Cited by 775
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009) · Nature · doi:10.1038/nature08538 · Cited by 702
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers
Schuff, N., Woerner, N., Boreta, L., Kornfield, T., Shaw, L. M., Trojanowski, J. Q., Thompson, P. M., Jack, C. R., Weiner, M. W., & Initiative, T. A. D. N. (2008) · Brain · doi:10.1093/brain/awp007 · Cited by 679
Effects of the DASH Diet Alone and in Combination With Exercise and Weight Loss on Blood Pressure and Cardiovascular Biomarkers in Men and Women With High Blood Pressure
Blumenthal, J. A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.470 · Cited by 606
The Trajectory of Gait Speed Preceding Mild Cognitive Impairment
Buracchio, T., Dodge, H. H., Howieson, D. B., Wasserman, D. K., & Kaye, J. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.159 · Cited by 575
Self-citation
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
Jack, C. R., Wiste, H. J., Vemuri, P., Weigand, S. D., Senjem, M. L., Zeng, G., Bernstein, M. A., Gunter, J. L., Pankratz, V. S., Aisen, P. S., et al. (2010) · Brain · doi:10.1093/brain/awq277 · Cited by 531
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI
Driscoll, I. F., Davatzikos, C. A., An, Y., Wu, X., Shen, D. G., Kraut, M. A., & Resnick, S. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a82634 · Cited by 527
Can Alzheimer disease be prevented by amyloid-β immunotherapy?
Lemere, C. A., & Masliah, E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.219 · Cited by 351
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease
Plant, C., Teipel, S. J., Oswald, A., Böhm, C., Meindl, T., Mourão-Miranda, J., Bokde, A. L. W., Hampel, H. J., & Ewers, M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.046 · Cited by 353
Ocular indicators of Alzheimer’s: exploring disease in the retina
Hart, N. J., Koronyo, Y., Black, K. L., & Koronyo‐Hamaoui, M. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1613-6 · Cited by 264
Evidence for Ordering of Alzheimer Disease Biomarkers
Jack, C. R. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.183 · Cited by 225
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
Bourgeat, P., Chételat, G., Villemagne, V. L., Fripp, J., Raniga, P., Pike, K., Acosta, O., Szoeke, C., Ourselin, S., Ames, D., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c918b5 · Cited by 220
Biomarkers of Alzheimer's disease
Craig‐Schapiro, R., Fagan, A. M., & Holtzman, D. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.003 · Cited by 228
Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson’s disease longitudinally
Hanganu, A., Bedetti, C., Degroot, C., Mejia‐Constain, B., Lafontaine, A., Soland, V., Chouinard, S., Bruneau, M., Mellah, S., Belleville, S., et al. (2014) · Brain · doi:10.1093/brain/awu036 · Cited by 223
Traumatic brain injury, neuroimaging, and neurodegeneration
Bigler, E. D. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00395 · Cited by 210
Sleep Duration and Age-Related Changes in Brain Structure and Cognitive Performance
Lo, J. C.-Y., Loh, K. K., Zheng, H., Sim, S. K. Y., & Chee, M. W. L. (2014) · SLEEP · doi:10.5665/sleep.3832 · Cited by 191
Cerebral atrophy in mild cognitive impairment and Alzheimer disease
Leung, K. K., Bartlett, J. W., Barnes, J., Manning, E. N., Sebastien Ourselin, A., Fox, N. C., & Initiative, A. D. N. (2013) · Neurology · doi:10.1212/wnl.0b013e318281ccd3 · Cited by 171
Trajectory of mild cognitive impairment onset
Howieson, D. B., Carlson, N. E., Moore, M. M., Wasserman, D. K., ABENDROTH, C. D., Payne-Murphy, J. C., & Kaye, J. A. (2008) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617708080375 · Cited by 167
Self-citation
When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.
Karr, J. E., Graham, R., Hofer, S. M., & Terrera, G. M. (2018) · Psychology and Aging · doi:10.1037/pag0000236 · Cited by 161
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort
Caroli, A., & Frisoni, G. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.024 · Cited by 150
Shapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease
Jack, C. R., Vemuri, P., Wiste, H. J., Weigand, S. D., Lesnick, T. G., Lowe, V., Kantarci, K., Bernstein, M. A., Senjem, M. L., Gunter, J. L., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3405 · Cited by 145
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease
Dubois, B., Marie Chupin, A., Hampel, H. J., Lista, S., Cavedo, E., Croisile, B., Louis-Tisserand, G., Touchon, J., Bonafé, A., Ousset, P., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.10.003 · Cited by 140
Disease Tracking Markers for Alzheimer's Disease at the Prodromal (MCI) Stage
Drago, V., Babiloni, C., Bartrés‐Faz, D., Caroli, A., Bosch, B., Hensch, T., Didic, M., Klafki, H., Pievani, M., Jovicich, J., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0043 · Cited by 144
Vitamin B-12 and cognition in the elderly
Smith, A. D., & Refsum, H. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26947d · Cited by 125
Cognitive function and brain structure correlations in healthy elderly East Asians
Chee, M. W. L., Chen, K. H. M., Zheng, H., Chan, K. P. L., Isaac, V., Sim, S. K. Y., Chuah, L. Y. M., Schuchinsky, M., Fischl, B. R., & Ng, T. P. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.036 · Cited by 122
Progression of Atrophy in Alzheimer’s Disease and Related Disorders
Whitwell, J. L. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9175-1 · Cited by 122
Neuropathologic Basis of Age-Associated Brain Atrophy
Erten‐Lyons, D., Dodge, H. H., Woltjer, R. L., Silbert, L. C., Howieson, D. B., Kramer, P., & Kaye, J. A. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1957 · Cited by 130
Self-citation
The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease
Ritchie, C. W., & Ritchie, K. A. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001893 · Cited by 124
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls
Chou, Y.-Y., Leporé, N., Avedissian, C., Madsen, S. K., Parikshak, N., Hua, X., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., Toga, A. W., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.02.015 · Cited by 117
Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease
Laurent Younes, B., Albert, M., & Miller, M. I. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.04.009 · Cited by 111
Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease
Schmand, B. A., Huizenga, H. M., & van Gool, W. A. (2009) · Psychological Medicine · doi:10.1017/s0033291709991516 · Cited by 109
A longitudinal study of brain atrophy over two years in community-dwelling older individuals
Jiang, J., Sachdev, P. S., Lipnicki, D. M., Zhang, H., Liu, T., Zhu, W., Suo, C., Zhuang, L., Crawford, J., Reppermund, S., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.022 · Cited by 105
Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions
Brooks, L., & Loewenstein, D. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt52 · Cited by 107
The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease
Miller, M. I., Younes, L., Ratnanather, J. T., Brown, T., Trinh, H., Postell, E., Lee, D. S., Wang, M.-C., Mori, S., O'Brien, R., et al. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.09.001 · Cited by 88
Executive Functions and Neurocognitive Aging
Reuter‐Lorenz, P. A., Festini, S. B., & Jantz, T. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411469-2.00013-3 · Cited by 85
A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers
Lawrence, E., Vegvari, C., Ower, A. K., Hadjichrysanthou, C., de Wolf, F., & Anderson, R. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170261 · Cited by 89
Effect of intellectual enrichment on AD biomarker trajectories
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Machulda, M. M., Lowe, V. J., Mielke, M. M., Roberts, R. O., Gunter, J. L., Senjem, M. L., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002490 · Cited by 88
Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry
Hua, X., Gutman, B. A., Boyle, C. P., Rajagopalan, P., Leow, A., Yanovsky, I., Kumar, A., Toga, A. W., Jack, C. R., Schuff, N. W., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.079 · Cited by 80
Cognitive reserve and cortical thickness in preclinical Alzheimer’s disease
Pettigrew, C. A., Soldan, A., Zhu, Y., Wang, M., Brown, T., Miller, M. I., & Albert, M. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9581-y · Cited by 86
Longitudinal brain structure and cognitive changes over 8 years in an East Asian cohort
Leong, R. L. F., Lo, J. C.-Y., Sim, S. K. Y., Zheng, H., Tandi, J., Zhou, J. H., & Chee, M. W. L. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.10.016 · Cited by 82
Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia
Camicioli, R. M., Sabino, J., Gee, M., Bouchard, T. P., Fisher, N., Hanstock, C. C., Emery, D. J., & Martin, W. R. W. (2011) · Movement Disorders · doi:10.1002/mds.23700 · Cited by 65
Knowledge of Dementia Among the Australian Health Workforce: A National Online Survey
Annear, M. J. (2020) · Journal of Applied Gerontology · doi:10.1177/0733464817752085 · Cited by 64
The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and A lzheimer's disease
Tang, X., Holland, D., Dale, A. M., Laurent Younes, B., Miller, M. I., & Initiative, A. D. N. (2015) · Human Brain Mapping · doi:10.1002/hbm.22758 · Cited by 67
Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline
Nettiksimmons, J., Harvey, D. J., Brewer, J. B., Carmichael, O. T., DeCarli, C. S., Jack, C. R., Petersen, R. C., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.025 · Cited by 64
Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline
Chou, Y.-Y., Leporé, N., Saharan, P., Madsen, S. K., Hua, X., Jack, C. R., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., Toga, A. W., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.001 · Cited by 66
Traumatic brain injury and reserve
Bigler, E. D., & Stern, Y. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63521-1.00043-1 · Cited by 72
Brain structure and aging in chronic temporal lobe epilepsy
Dabbs, K., Becker, T., Jones, J. E., Rutecki, P. A., Seidenberg, M., & Hermann, B. P. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03447.x · Cited by 62
Technology, Cognitive Remediation, and Nursing: Directions for Successful Cognitive Aging
Vance, D. E., McNees, P., & Meneses, K. (2009) · Journal of Gerontological Nursing · doi:10.3928/00989134-20090201-09 · Cited by 57
Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study
Kinnunen, K. M., Cash, D. M., Poole, T., Frost, C. D., Benzinger, T. L. S., Ahsan, R. L., Leung, K. K., Cardoso, M. J., Marc Modat, A., Malone, I. B., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.06.2268 · Cited by 58
Home‐based technologies: A new paradigm for conducting dementia prevention trials
Kaye, J. A. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.003 · Cited by 56
Self-citation
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals
Lazarczyk, M. J., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-127 · Cited by 55
Comparison of phantom and registration scaling corrections using the ADNI cohort
Clarkson, M. J., Sebastien Ourselin, A., Nielsen, C. F., Leung, K. K., Barnes, J., Whitwell, J. L., Gunter, J. L., Hill, D., Weiner, M. W., Jack, C. R., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.045 · Cited by 54
Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer’s Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study
Duan, W., Zhou, G. D., Balachandrasekaran, A., Bhumkar, A. B., Boraste, P. B., Becker, J. T., Kuller, L. H., López, O. L., Gach, H. M., & Dai, W. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210199 · Cited by 51
Early stage alterations in white matter and decreased functional interhemispheric hippocampal connectivity in the 3xTg mouse model of Alzheimer’s disease.
Manno, F. A. M., Isla, A. G., Manno, S. H. C., Ahmed, I., Cheng, S. H., Barrios, F. A., & Lau, C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00039 · Cited by 49
Tipping points in neurodegeneration
Simons, M., Levin, J., & Dichgans, M. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.031 · Cited by 52
Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation
Perrin, R. J., Payton, J. E., Malone, J. P., Erdmann-Gilmore, P., Davis, A., Xiong, C., Fagan, A. M., Townsend, R. R., & Holtzman, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064314 · Cited by 50
Volume Analysis of Brain Cognitive Areas in Alzheimer’s Disease: Interim 3-Year Results from the ASCOMALVA Trial
Traini, E., Carotenuto, A., Fasanaro, A. M., & Amenta, F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190623 · Cited by 46
Biomarkers Predicting Alzheimer's Disease in Cognitively Normal Aging
Shim, Y. S., & Morris, J. C. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.2.60 · Cited by 41
Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions
Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9190-2 · Cited by 34
Executive functions and neurocognitive aging
Reuter‐Lorenz, P. A., Festini, S. B., & Jantz, T. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816094-7.00019-2 · Cited by 38
Effects of Physical Exercise Combined with Nutritional Supplements on Aging Brain Related Structures and Functions: A Systematic Review
Schättin, A., Baur, K., Stutz, J., Wolf, P., & de Bruin, E. D. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00161 · Cited by 33
Early Indications of Future Cognitive Decline: Stable versus Declining Controls
Rizk‐Jackson, A., Insel, P. S., Petersen, R. C., Aisen, P. S. S., Jack, C. R., & Weiner, M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074062 · Cited by 34
The FAS gene, brain volume, and disease progression in Alzheimer's disease
Erten‐Lyons, D., Jacobson, A., Kramer, P., Grupe, A., & Kaye, J. A. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.663 · Cited by 33
Self-citation
Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults
Armstrong, N. M., Huang, C.-W., Williams, O. A., Bilgel, M., An, Y., Doshi, J. J., Erus, G., Davatzikos, C. A., Wong, D. F., Ferrucci, L., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101769 · Cited by 31
11β-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline
MacLullich, A. M. J., Ferguson, K. J., Reid, L. M., Deary, I. J., Starr, J. M., Wardlaw, J. M., Walker, B. R., Andrew, R., & Seckl, J. R. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.010 · Cited by 33
Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease
Beyer, M. K., Alves, G. W., Hwang, K., Babakchanian, S., Brønnick, K., Chou, Y., Dalaker, T. O., Kurz, M. W., Larsen, J. O., Somme, J. H., et al. (2013) · Movement Disorders · doi:10.1002/mds.25282 · Cited by 28
Structural Brain Alterations before Mild Cognitive Impairment in ADNI: Validation of Volume Loss in a Predefined Antero-Temporal Region
Smith, C. D., Initiative, A. D. N., Andersen, A. H., & Gold, B. T. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120157 · Cited by 30
Alzheimer's disease biomarkers: correspondence between human studies and animal models
Sabbagh, J. J., Kinney, J. W., & Cummings, J. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.04.010 · Cited by 27
Neuroimaging in the Oldest-Old: A Review of the Literature
Woodworth, D. C., Scambray, K. A., Corrada, M. M., Kawas, C. H., & Sajjadi, S. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201578 · Cited by 28
Differential Relationships Between Brain Structure and Dual Task Walking in Young and Older Adults
Hupfeld, K. E., Geraghty, J. M., McGregor, H. R., Hass, C. J., Pasternak, O., & Seidler, R. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.809281 · Cited by 28
Longitudinal imaging: change and causality
Whitwell, J. L. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32830719d4 · Cited by 23
Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis
Andrews, K. A., Frost, C. D., Marc Modat, A., Cardoso, M. J., Rowe, C. C., Villemagne, V. L., Fox, N. C., Sebastien Ourselin, A., Schott, J. M., Rowe, C. C., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.013 · Cited by 23
Expanding ventricles may detect preclinical Alzheimer disease
Weiner, M. W. (2008) · Neurology · doi:10.1212/01.wnl.0000304743.72127.cc · Cited by 21
Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer’s Disease
Zeifman, L. E., Eddy, W. F., López, O. L., Kuller, L. H., Raji, C. A., Thompson, P. M., & Becker, J. T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150047 · Cited by 21
Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer’s disease based on multi-modal MRI techniques
Hu, Z., Wu, L., Jia, J., & Han, Y. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1407-y · Cited by 20
Preventing Vascular Effects on Brain Injury and Cognition Late in Life: Knowns and Unknowns
Carmichael, O. T. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9264-7 · Cited by 19
Patterns of Compensation and Vulnerability in Normal Subjects at Risk of Alzheimer's Disease
López, O. L., Becker, J. T., & Kuller, L. H. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129015 · Cited by 20
Differentiating Mild Cognitive Impairment and Cognitive Changes of Normal Aging
Mosti, C. B., Rog, L. A., & Fink, J. W. (2019) · Clinical handbooks in neuropsychology · doi:10.1007/978-3-319-93497-6_28 · Cited by 18
A Comparative Analysis of MRI Automated Segmentation of Subcortical Brain Volumes in a Large Dataset of Elderly Subjects
Gómez‐Ramírez, J., Quilis-Sancho, J., & Fernández‐Blázquez, M. A. (2021) · Neuroinformatics · doi:10.1007/s12021-021-09520-z · Cited by 17
IC‐P‐122: Atrophy‐specific MRI brain template for Alzheimer's disease and mild cognitive impairment
Fonov, V., Pierrick Coupé, A., Eskildsen, S. F., & Collins, D. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.087 · Cited by 17
20 Brain Imaging in the Evaluation of Putative Alzheimer’s Disease-Slowing, Risk-Reducing and Prevention Therapies
Reiman, E. M., & Langbaum, J. B. S. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0020 · Cited by 16
Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging
Liu, S., Cai, W., Pujol, S., Kikinis, R., & Feng, D. D. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00023 · Cited by 17
Future Screening for Incipient Alzheimer’s Disease – The Influence of Prevalence on Test Performance
Mattsson, N., & Zetterberg, H. (2009) · European Neurology · doi:10.1159/000228591 · Cited by 15
Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET
Stonnington, C. M., Chen, Y., Savage, C. R., Lee, W., Bauer, R. J., III, Sharieff, S., Thiyyagura, P., Alexander, G. E., Caselli, R. J., Locke, D. E. C., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170852 · Cited by 14
Brain ventricles, CSF and cognition: a narrative review
Júnior, M. L. D. M. S., Diniz, P. R. B., Vilanova, M. V. D. S., Basto, G. P. T., & Valênça, M. M. (2022) · Psychogeriatrics · doi:10.1111/psyg.12839 · Cited by 15
White matter hyperintensities and the surrounding normal appearing white matter are associated with water channel disruption in the oldest old
Silbert, L. C., Roese, N. E., Krajbich, V., Hurworth, J., Lahna, D. L., Schwartz, D. L., Dodge, H. H., & Woltjer, R. L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13816 · Cited by 13
Self-citation
Question and Answer Session =
(1982) · NASSP Bulletin · doi:10.1177/019263658206645308 · Cited by 13
Cortical gray to white matter signal intensity ratio as a sign of neurodegeneration and cognition independent of β‐amyloid in dementia
Xu, X., Jang, I., Zhang, J., Zhang, M., Wang, L., Ye, G., Zhao, A., Zhang, Y., Li, B., Liu, J., et al. (2023) · Human Brain Mapping · doi:10.1002/hbm.26532 · Cited by 12
Exercise and Cognitive Function: Can Working Out Train the Brain, Too?
Zoeller, R. F. (2010) · American Journal of Lifestyle Medicine · doi:10.1177/1559827610374413 · Cited by 14
Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer’s Disease
Snir, J. A., Suchý, M., Lawrence, K. S., Hudson, R. H. E., Pasternak, S., & Bartha, R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150123 · Cited by 13
Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women
Sapkota, S., Ramirez, J., Stuss, D. T., Masellis, M., & Black, S. E. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0419-2 · Cited by 12
Structural imaging in early pre-states of dementia
Smith, C. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.002 · Cited by 11
Structural Magnetic Resonance Imaging Markers of Alzheimer’s Disease and Its Retranslation to Rodent Models
Kincses, Z. T., Király, A., Veréb, D., & Vécsei, L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143195 · Cited by 10
Mild Cognitive Impairment and Normal Aging
Rog, L. A., & Fink, J. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3106-0_16 · Cited by 10
Memory Development across the Life Span
Ornstein, P. A., & Light, L. L. (2010) · Wiley eBooks · doi:10.1002/9780470880166.hlsd001009 · Cited by 10
Biomechanical perspectives on traumatic brain injury in the elderly: a comprehensive review
Abdi, H., Sánchez‐Molina, D., Vilana, S. G., & Rahimi-Movaghar, V. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ada654 · Cited by 9
Stages of Biological Development across Age: An Analysis of Canadian Health Measure Survey 2007–2011
Chao, Y., Wu, H., Wu, C.-J., & Chen, W. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00355 · Cited by 9

Authors: Carlson, N. E., Moore, M. M., Dame, A., Howieson, D., Silbert, L. C., Quinn, J. F., & Kaye, J. A.
Affiliations: Oregon Health & Science University (US)
ORCID: Carlson, N. E.
Silbert, L. C.
Quinn, J. F.
Kaye, J. A.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2008-03-11
Volume: 70
Issue: 11
Pages: 828-833
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/01.wnl.0000280577.43413.d9
OpenAlex: W1980529166
Cited by: 144
References: 31
Citations by year: 2026: 2 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 10 · 2013: 10 · 2012: 10
FWCI: 9.08
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (AG 08017, K01AG030514, P30AG008017)
National Center for Research Resources (UL1RR024140)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords: brain atrophy, ventriculomegaly, mild cognitive impairment, healthy aging, dementia prevention, longitudinal brain volume change
MeSH terms: Aged, Aged, 80 and over, Aging, Alzheimer Disease, Atrophy, Brain, Cerebral Ventricles, Cognition Disorders, Female, Follow-Up Studies, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Cohort Studies, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trajectories of brain loss in aging and the development of cognitive impairment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks